Around 10% of the worldwide population was affected by chronic kidney disease fostering growth of the medical membrane market

 

The growing prevalence of infectious chronic diseases such as chronic kidney disease around the globe is augmenting the growth of the medical membrane market. According to the National Kidney Foundation 2018, data around 10% of the worldwide population was affected by chronic kidney disease. Moreover, growing government initiatives in research and development, development in the healthcare industry, pharmaceutical, biotechnology industry, and rising adoption of medical membranes across several industries are major factors propelling the growth of the medical membrane market. On the other hand, high capital investment for the production of membrane and surface fouling is estimated to restrict the growth of the market.

The key players operating in the global medical membrane market include Nipro Corporation, Amniox, Pall Corporation, Sorin Group, Gore, Maquet Company, Merck Millipore, and others

In November 2018, Merck, the vibrant science and technology company launched its new BioContinuum™ Platform to advance biotherapeutic drug manufacturing through improved efficiency, simplified plant operations, and greater quality and consistency

North America is expected to exhibit significant growth over the forecast period and this is attributed to the high prevalence of chronic disease in the region. According to the National Health Council, chronic diseases affect approximately 133 million Americans, representing more than 40% of the total population of this country.2 By 2020, that number is projected to grow to an estimated 157 million, with 81 million having multiple conditions. Moreover, growing initiatives by the government to reduce the mortality associated with kidney disease are also projected to foster the growth of the market. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), aims to reduce the mortality and morbidity linked with kidney disease by introducing the initiative National Kidney Disease Education Program.

Medical membranes are manufactured for use in separation processes across the medical industry for use in various applications. They provide high-speed filtration of microorganisms, fungi, and other particles in aqueous solutions to filter out microorganisms, bacteria, and viruses. In addition, medical membranes are widely used in pre-filtration, pretest, analytical method development, dry cell filtering, dilution, analytical method development, dilutive dialysis, sorption, electrodialysis, capillary free flow, submicron filtration, and expression method development. They are also commonly used to cleanse the air, for mechanical ventilation and environmental cleanliness purposes. Medical membranes can be made of vinyl, polyvinyl chloride, polypropylene, ethylene, or other membranes commonly used in many industries.